Community Health Worker Post-Discharge Intervention
BehavioralClients will be offered a community-based follow-up from a community health worker after hospital discharge.
NCT Number: NCT05694546
Early post-discharge mortality is high among Zambians living with HIV admitted to the hospital. This may be due to missed opportunities in post-discharge care, such as inadequate follow-up and treatment. In this study the investigators will develop and pilot a new approach to post-discharge HIV care to improve care coordination and treatment adherence.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Levy Mwanawasa University Teaching Hospital, Lusaka, Zambia
Many people living with HIV (PLHIV) have poor outcomes following hospitalization, including high mortality, readmission, and gaps in HIV care engagement. This is likely multi-factorial and not all etiologies may be modifiable. While high mortality may due to incurable cancer, the majority of deaths in PLHIV are thought to be caused by infectious diseases for which treatments exist. However, succumbing to these life-threatening infections after discharge may be due to poor understanding of discharge instructions, lack of post hospital care, and poor understanding of required follow up. Psychosocial support also plays a role in the mental and physical health of these sick patients.
In ReCharge 1, the investigators gathered formative data and identified at least three major factors that undermine HIV clinical outcomes after hospital discharge. First, there are gaps in continuity of care between the discharging facility and outpatient. Second, support from family is often suboptimal due to lack of understanding on the cause of illness, lack of HIV status disclosure, and the cost of care. Third, HIV comorbidities may underpin or complicate the immediate reason for discharge or the post-discharge engagement in care. These data were disseminated to local experts in Zambia including from the Ministry of Health and used to create a new care model for post-discharge HIV care. The care model draws from other successful programs in Zambia. In ReCharge 2 the investigators now propose to pilot the program and assess feasibility, acceptability, and potential for clinical impact.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Clients will be offered a community-based follow-up from a community health worker after hospital discharge.
Time frame: Through three months post-discharge
Proportion of discharged patients who are successfully visited after discharge.
Time frame: Through three months post-discharge
Number of participants that receive a comprehensive discharge follow-up visit from a community health worker
Time frame: Through three months post-discharge
Proportion of initial post-discharge visits to the HIV clinic that are attended by the participant's community health worker
Time frame: 6 months post-discharge
Proportion of clients with suppressed HIV viral load at 6 months post-discharge.
Time frame: 6 months post-discharge
Proportion of clients alive at 6 months post-discharge.
Time frame: 6 months post-discharge
Retention in HIV care after discharge defined by no gap of >28 days off antiretroviral therapy from discharge date to 6 months post-discharge date
Time frame: 1 month post-discharge
Antiretroviral therapy clinic visit within 1 month of discharge
University of Maryland, Baltimore
Other
Re-engagement at Discharge 2: Improving Post-hospital Outcomes for Adults With HIV in Zambia
Acronym: ReCharge2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04033718
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Lusaka, Zambia
View Trial DetailsNCT05609513
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Kampala, Uganda
View Trial DetailsNCT06739915
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Soweto, Gauteng, South Africa
View Trial DetailsNCT04446611
Acquired Immunodeficiency Syndrome, Antenatal Care
East London, Eastern Cape, South Africa
View Trial Details